218
Participants
Start Date
February 28, 2022
Primary Completion Date
February 28, 2027
Study Completion Date
February 28, 2027
Faricimab
Participants will receive 6-milligram (mg) faricimab intravitreal (IVT) injections, as described in the study arm descriptions for each study phase.
Scheie Eye Institute, Philadelphia
Wills Eye Hospital, Philadelphia
Md Medical Research, Oxon Hill
Wagner Kapoor Institute, Norfolk
Piedmont Eye Center, Lynchburg
Fort Lauderdale Eye Institute, Plantation
Charles Retina Institute, Memphis
Black Hills Eye Institute, Rapid City
University Retina and Macula Associates, PC, Oak Forest
Strategic Clinical Research Group, LLC, Willow Park
Retina Center of Texas, Southlake
Austin Clinical Research LLC, Austin
Southwest Retina Consultants, Durango
Barnet Dulaney Perkins Eye Center, Phoenix
Retina Consultants of Nevada, Henderson
Sierra Eye Associates, Reno
Kaiser Permanente Southern California, Los Angeles
Win Retina, Arcadia
Retina Consultants of Orange County, Fullerton
Retinal Diagnostic Center, Campbell
Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh
M & J Western Regional Institute of Ophthalmology, Ahmedabad
PBMA'S H. V. Desai Eye Hospital, Pune
MM Joshi Eye Institute, Hubli
Sankara Nethralaya, Chennai
Aravind Eye Hospital, Madurai
Regional Institute of Ophthalmology, Kolkata
Retinal Consultants Medical Group, Sacramento
Emerson Clinical Research Institute LLC, Washington D.C.
Blue Ocean Clinical Research, Clearwater
Retina Macula Specialists of Miami - LeJeune Road Office, Miami
Florida Retina Institute, Orlando
Wilmer Eye Institute Johns Hopkins University, Baltimore
Retina Associates of Michigan, Grand Blanc
The Retina Center of New Jersey, Bloomfield
NJ Retina - Teaneck, Teaneck
Piedmont Retina Specialists, Winston-Salem
Retina Associates of Cleveland, INC, Beachwood
Retina & Vitreous of Texas, Bellaire
Brown Retina Institute, San Antonio
Nairobi Hospital, Nairobi
City Eye Hospital, Nairobi
Emanuelli Research and Development Center LLC, Arecibo
Lead Sponsor
Genentech, Inc.
INDUSTRY